March 27, 2015

Massachusetts Life Sciences Center Announces Capital Grant Awards and Funding for Equipment and Supplies in Western Mass

SPRINGFIELD – March 27, 2015 – The Massachusetts Life Sciences Center (MLSC) today joined elected officials and school leaders at Springfield Technical Community College (STCC) to announce more than $2 million in funding for life-sciences-related capital projects and nearly $400,000 in grants to purchase equipment and supplies for high schools and middle schools in Western Massachusetts.

STCC Grant Announcement 3_2745

President & CEO of the Massachusetts Life Sciences Center Dr. Susan Windham-Bannister (center) joined Western Massachusetts capital award and equipment and supply grant recipients for an announcement at Springfield Technical Community College.

 

Read the press release here

March 18, 2015

Massachusetts Life Sciences Center Awards Tax Incentives to 11 Companies

The Massachusetts Life Sciences Center (MLSC) announced that the agency’s Board of Directors has awarded $19 million in tax incentives to 11 life sciences companies. The recipient companies have committed to creating 1075 new jobs in the Commonwealth in 2015.

The Life Sciences Tax Incentive Program was established in 2008 as part of Massachusetts’ 10-year, $1 billion Life Sciences Initiative. The program authorizes tax incentives each year for companies engaged in life sciences research and development, commercialization and manufacturing. The primary goal of the program is to incentivize life sciences companies to create new sustained jobs in Massachusetts.

 

Read the press release here »

March 18, 2015

Massachusetts Life Sciences Center, Local and School Officals Announce More Than $17 Million in Grants for Capital Projects, Equipment and Supplies in Greater Boston

The Massachusetts Life Sciences Center (MLSC) joined elected officials and local school leaders at Roxbury Community College to announce more than $17 million in funding for life sciences-related capital projects and nearly $800,000 in grants to purchase equipment and supplies for high schools and middle schools in the Greater Boston area.

The capital grants were awarded to educational institutions and medical centers in Boston and Cambridge, including $3 million in funding for Roxbury Community College (RCC) to upgrade and equip its currently outdated lab training facilities. Other institutions and programs that are receiving grants include the Boston University Business Innovation Center, Boston University Medical School and Boston Medical Center, Boston Children’s Hospital, the Forsyth Institute jointly with Brigham & Women’s Hospital, Just-A-Start (JAS) Corporation and the Massachusetts Institute of Technology (MIT).

Jorge Bonilla, the Student Trustee at Roxbury Community College, participates in the announcement of the Massachusetts Life Sciences Center’s capital awards in the greater Boston region, including a $3 million grant for the construction of new training facilities at Roxbury Community College. Also pictured from left to right are: MLSC President & CEO Dr. Susan Windham-Bannister, Ph.D., President of RCC Dr. Valerie Roberson, State Representative Russell Holmes and City of Boston Chief of Education Turahn Dorsey.

Jorge Bonilla, the Student Trustee at Roxbury Community College, participates in the announcement of the Massachusetts Life Sciences Center’s capital awards in the greater Boston region, including a $3 million grant for the construction of new training facilities at Roxbury Community College. Also pictured from left to right are: MLSC President & CEO Dr. Susan Windham-Bannister, Ph.D., President of RCC Dr. Valerie Roberson, State Representative Russell Holmes and City of Boston Chief of Education Turahn Dorsey.

Read the press release here »

March 16, 2015

Massachusetts Life Sciences Center and international partners announce new grants through International Collaborative Industry Program

The Massachusetts Life Sciences Center (MLSC) and six international partner agencies today announced the second round of grants through the MLSC’s International Collaborative Industry Program (ICIP).  Four new projects have been awarded funding through the current round of the program.

Kew Group (Located in Cambridge, MA) in partnership with DiaTech Oncology in Quebec, Canada

This collaboration is focused on the development of innovative strategies to provide both functional (in vitro chemosensitivity) and genomic (DNA sequence-based) information to cancer patients and their oncologists, so that optimal combination therapeutic decisions can be made in a timely fashion. This project creates synergies in cancer diagnostics that capitalize on the strengths of each individual company.

Lantern Pharma (Located in Cambridge, MA) in partnership with Oncology Venture in Medicon Valley, Denmark.

These companies will conduct an early clinical trial using Irofluven (developed by Lantern Pharma) to treat prostate cancer, in selected patients based on genetic analysis of tumor samples (conducted by Oncology Venture), which identifies the patients most likely to respond to Irofluven. The outcome may lead to improved treatment for cancer patients, who otherwise have limited treatment options.

Q-State Biosciences (Located in Cambridge, MA) in partnership with Anagenesis Biotechnologies in Alsace, France

This collaboration will involve development of a platform to screen for drugs to treat Duchenne Muscular Dystrophy (DMD), one of the most prevalent inherited diseases in young males. The companies will use a new detection system developed by Q-State to modify novel cells derived from Duchenne Muscular Dystrophy muscle, developed by Anagenesis. The project will build on Anagenesis’ expertise in induced pluripotent stem cell (iPSC)-derived skeletal muscle cells and DMD models, and on Q-State Biosciences’ all-optical, non-invasive recordings of electrophysiological parameters.

Triton Systems Inc. (Located in Chelmsford, MA) in partnership with Grey Innovation in Victoria, Australia

For this collaboration, the team will combine Grey Innovation’s non-invasive wrist-worn hypoglycemia detection device and Triton’s mobile disease management solution to develop an m-Health system for monitoring and managing otherwise potentially fatal hypoglycemic events in Type-1/Type-2 diabetes. The system will ensure personal health privacy and improve patient compliance and outcomes.

Read the press release here »

March 11, 2015

Massachusetts Life Sciences Center Announces Equipment and Supply Grants for Revere Schools

The Massachusetts Life Sciences Center (MLSC), joined by House Speaker Robert A. DeLeo and local school and elected officials announced more than $246,000 in funding to improve science courses, and provide new equipment and supplies for students in the Revere Public Schools.

An MLSC grant of $96,000 will support the improvement of Revere High School’s Chemistry, Physics and Computer Science programs, both at the Introductory and Advanced Placement levels. This funding will provide up-to-date equipment and supplies so students have more opportunities to design experiments or prototypes, collect data and analyze the results, or to collaborate with peers to solve complex problems. Additional funding of nearly $150,000 was awarded to three Revere middle schools (Garfield Middle School, Rumney Marsh Academy, and the Susan B. Anthony Middle School).

Speaker DeLeo, Revere school committee member and former Superintendent Carol Tye, and a student from Garfield Middle School in Revere during the MLSC equipment and supply grant announcement event at Revere High School.

Speaker DeLeo, Revere school committee member and former Superintendent Carol Tye, and a student from Garfield Middle School in Revere during the MLSC equipment and supply grant announcement event at Revere High School.

Read the press release here »

February 27, 2015

WuXi AppTec Opens Office in Cambridge, Massachusetts

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries with operations in China and the United States, celebrated the grand opening of its innovation hub network office in Cambridge, Massachusetts. A ribbon-cutting ceremony, followed by a special WuXi forum – “Massachusetts: The Convergence of Science, Capital & Innovation”, was held at the Cambridge Marriott.

The forum also featured keynote addresses and a panel discussion on the symbiotic relationship of the local ecosystem and innovation that featured Josh Boger, Executive Chairman, Alkeus and Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center among others.

Counselor Dongbai Ye of the Chinese Consulate in New York, Senior Vice President of WuXi AppTec Inc. and Head of the WuXi Cambridge Office Dr. Richard Soll, Vice Mayor of Cambridge Dennis Benzan and the President & CEO of the MLSC Susan Windham-Bannister, Ph.D. participate in a ribbon-cutting to celebrate the opening of WuXi’s new facility in Cambridge.

Read the press release here »

February 26, 2015

Dicerna Pharmaceuticals Announces Move to Larger Office and Lab Space in Cambridge, Massachusetts

Relocation Reflects Company’s Continued Growth and Accommodates Future Expansion

Cambridge, Mass., February 26, 2015 – Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi therapeutics, today celebrates the opening of a new 37,000 square-foot office and state-of-the-art research and development (R&D) laboratory at 87 Cambridgepark Drive, in Cambridge’s Alewife neighborhood. Mayor of Cambridge David Maher, Vice Mayor of Cambridge Dennis Benzan, State Representative Jay Livingstone, Massachusetts Life Sciences Center President & CEO Susan Windham-Bannister, Ph.D., and MassBio President & CEO Robert Coughlin will attend a reception and ribbon cutting ceremony at Dicerna this afternoon to mark this important occasion.

DSCN1781

Robert Coughlin, President & CEO of MassBio, Dennis A. Benzan, Vice Mayor of Cambridge, Douglas Fambrough, Ph.D., CEO of Dicerna, David P. Maher, Mayor of Cambridge and Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center participate in a ribbon-cutting to celebrate Dicerna’s new facility in Cambridge.

      

Read the press release here »

January 21, 2015

Massachusetts Life Sciences Center Awards Avaxia Biologics a Universal Partnerships (UP) Program Grant

The Massachusetts Life Sciences Center (MLSC) and Lexington-based Avaxia Biologics, Inc. announced that Avaxia has been awarded one of the first grants through MLSC’s new Universal Partnerships (UP) Program. The grant will support an international research collaboration between Avaxia and Delphi Genetics SA of the Wallonia region of Belgium. Under the collaboration, Avaxia and Delphi will develop an improved manufacturing process for Avaxia’s lead product candidate, AVX-470, which is in clinical development for the treatment of ulcerative colitis.

The goal of this grant is to develop an improved immunization process to increase the amount of AVX-470 that each cow produces. Delphi Genetics brings proprietary technology and expertise in novel DNA vaccine immunization approaches and other immunization technologies that have successfully generated strong antibody responses in animals.

Read the press release here »

December 17, 2014

Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans

The Massachusetts Life Sciences Center (MLSC), a quasi-public agency charged with implementing the state’s 10-year, $1-billion Life Sciences Initiative, announced the awarding of $2 million in loans to two early-stage life sciences companies and the launch of the eleventh round of its Accelerator Loan Program. The MLSC will be accepting applications for the next round of the program beginning on December 18, with applications due by noon EST on February 2, 2015

Read the press release here »

December 17, 2014

Massachusetts Life Sciences Center Announces New Appointee to Board of Directors

The Massachusetts Life Sciences Center (MLSC) announced today that Governor Deval Patrick has appointed Peter Parker, President of BioInnovation, to the MLSC Board of Directors.

Mr. Parker has served as President of BioInnovation, LLC, a Cambridge, MA based provider of start-up capital and services to life sciences companies, since August 2010. In 2012, he became one of three co-founders of LabCentral, Inc, a new non-profit for companies who need shared laboratory space in Kendall Square.  Mr. Parker also currently serves as a senior advisor to Ampersand Capital Partners, where he previously served as a General Partner from 1988-2006 and helped launch their healthcare franchise.

Read the press release here »

December 16, 2014

Governor Patrick, Massachusetts Life Sciences Center Announce $1 Million Grant to Fund Research and Development of Ebola Diagnostic Test

Governor Deval Patrick and the Massachusetts Life Sciences Center (MLSC) announced a $1 million challenge grant to support a partnership of life sciences companies, NGO’s and academic institutions, led by Diagnostics For All, that is working to develop an improved, fast and accurate diagnostic test for Ebola. Participating organizations in the partnership include Diagnostics For All (DFA), Harvard University, the Broad Institute, UMass Medical School, GE Healthcare, Cambridge Consultants, Eiken, BBI Solutions, IMPACT Technology Development and WellBody Alliance in Sierra Leone. The goal of the partnership is to speed the launch of an improved Ebola diagnostic tool to within months versus years. The test, incorporating isothermal nucleic acid amplification on a paper substrate, is simple to administer and is the first of its kind to offer disposable molecular diagnostics (MDx) capabilities without requiring analysis in a laboratory or additional instruments, as needed for current MDx tests.  The reduced cost and ease of use is expected to facilitate earlier diagnosis of Ebola and in many more settings than is currently possible.

Read the press release here »

December 11, 2014

Massachusetts Life Sciences Center Announces Second Round of Massachusetts Neuroscience Consortium Grants

The Massachusetts Life Sciences Center (MLSC) and six global biopharmaceutical companies announced six awards made to researchers through the Massachusetts Neuroscience Consortium. The announcement was the second round of awards made by the Consortium, which was launched in June 2012 at the Bio International Convention in Boston.

Read the press release here »

December 10, 2014

Governor Patrick Announces $100K Grant for Professional Development Program Aimed at Increasing Diversity in the Life Sciences Industry

Governor Deval Patrick announced that the Massachusetts Life Sciences Center (MLSC) will be providing a $100,000 grant to The Partnership, Inc. in order to develop a diversity-focused professional development program that will maximize the training and retention of underrepresented minorities working in the life sciences industry. The funds will be used for research, program creation, implementation, and evaluation.

from left to right: Liz Cheng (WGBH's General Manager for Television), Governor Deval Patrick and First Lady Diane Patrick participate in a fireside chat to discuss the importance of expanding opportunities to people of color at The Partnership’s Annual Meeting

from left to right: Liz Cheng (WGBH’s General Manager for Television), Governor Deval Patrick and First Lady Diane Patrick participate in a fireside chat to discuss the importance of expanding opportunities to people of color at The Partnership’s Annual Meeting

Read the press release here »

December 1, 2014

Governor Patrick Visits inviCRO, Celebrates New Collaboration Stemming From Israel Trade Mission

BOSTON, MA – Last week Governor Deval Patrick visited inviCRO, a fast-growing Boston life sciences firm, to join in announcing the company’s expanded development agreement with Israel-based Aspect Imaging. The commercial agreement comes as a direct result of the Governor’s recent Innovation Partnership Mission to Israel. inviCRO was represented as part of the life sciences delegation on the mission. The extended software development contract with Aspect Imaging will seek to develop advanced imaging analysis tools for the company’s innovative, compact MRI platform.inviCRO_©HOGGER&Co._2014_064

Photo caption from left to right: Jack Hoppin, inviCRO Co-Founder and Managing Director; Marc Seaman, inviCRO Imaging Scientist; Deval Patrick, Governor of the Commonwealth of Massachusetts; Maurice “Mo” Cowan, Former U.S. Senator; Matt Silva, inviCRO Senior Director of Imaging Research; and (behind) the inviCRO Lab Team celebrate inviCRO’s expanded development agreement with Israel-based Aspect Imaging. *Photography by Hogger & Co.

Read the press release here »

November 21, 2014

Massachusetts Life Sciences Center Launches Fourth Round of Cooperative Matching Research Grant Program

The Massachusetts Life Sciences Center (MLSC) has launched a fourth round of its Cooperative Research Matching Grant Program. The MLSC will begin accepting online applications for the program November 21st to February 13, 2015 by 12:00 p.m. EST at www.masslifesciences.com.  The MLSC’s Cooperative Research Matching Grants seek to increase industry-sponsored research at academic institutions in Massachusetts in order to accelerate scientific discoveries that lead to commercially-viable products and therapies.

Read the press release here »

Connect With Us

Facebook LinkedIn Twitter